Klaria Klaria Pharma Holding is a company that develops pharmaceuticals for migraine, cancer-related pain, and opioid overdoses. | ![]() Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | ||
Founding Date | Founding Date 2014 | Founding Date 1994 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Uppsala, SE HQ | Locations Alameda, US HQ | Locations San Diego, US HQ |
Employees | Employees 4 | Employees 1,14712% decrease | Employees 373157% increase |
Valuation ($) | Valuation ($) 7.8 m | Valuation ($) 8.2 b | Valuation ($) 6.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) kr9m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) | Cost of goods $228.8m (FY, 2025) |
Gross profit | Gross profit kr9m (FY, 2025) | Gross profit $2.2b (FY, 2025) | Gross profit $1.2b (FY, 2025) |
Net income | Net income (kr38.9m) (FY, 2025) | Net income $782.6m (FY, 2025) | Net income $316.9m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 3.3m | Total funding raised N/A | Total funding raised $ 171.9m |

Exelixis is an oncology company that develops cancer treatments.
View company
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View company